Dareon-Lung-1 will test obrixtamig plus Tecentriq and chemo in small-cell lung cancer.
ApexOnco Front Page
Recent articles
The Sentry trial hits on spleen volume reduction, but misses on symptoms.
But Tevimbra’s role looks shaky as adverse events loom.
Four months after yielding first-in-human data INCA33890 enters phase 3.
Seven oncology approvals included nods for subcutaneous Rybrevant and Lunsumio.
The company hands its PD-L1 x VEGF bispecific back to ImmuneOnco.
Mocertatug rezetecan is starting its first western pivotal trials.
PersonGen’s LV009 takes the industry tally of clinical-stage projects to 14.
